Monocyte Chemotactic Protein-1 (MCP1) Accumulation in Human Osteoclast Precursor Cultures
In vitro osteoclast methods require constant treatment with macrophage colony stimulating factor (M-CSF) to support precursor survival and addition of the differentiation agent receptor activator of NF-κB ligand (RANKL). Constant exposure to granulocyte macrophage colony stimulating factor (GM-CSF)...
Main Authors: | Nigel A. Morrison, Mark R. Forwood |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Life |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-1729/12/6/789 |
Similar Items
-
A GM-CSF and DOX co-delivery nanoplatform modulates macrophage polarization to promote tumor suppression
by: Miao Wang, et al.
Published: (2023-04-01) -
Better approach for autoimmune pulmonary alveolar proteinosis treatment: inhaled or subcutaneous granulocyte-macrophage colony-stimulating factor: a meta-analyses
by: Gaohong Sheng, et al.
Published: (2018-08-01) -
Modulación de la expresión de la L-selectina por agentes quimiotácticos y GM-CSF
by: Carlos J. Montoya, et al.
Published: (2002-03-01) -
Extracellular Matrix-Induced GM-CSF and Hypoxia Promote Immune Control of Mycobacterium tuberculosis in Human In Vitro Granulomas
by: Ainhoa Arbués, et al.
Published: (2021-09-01) -
Correction of a chronic pulmonary disease through lentiviral vector-mediated protein expression
by: Helena Lund-Palau, et al.
Published: (2022-06-01)